GRASSILLI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 1.811
EU - Europa 911
AS - Asia 450
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.173
Nazione #
US - Stati Uniti d'America 1.802
IT - Italia 393
PL - Polonia 296
CN - Cina 164
SG - Singapore 161
DE - Germania 62
UA - Ucraina 62
TR - Turchia 59
ID - Indonesia 47
GB - Regno Unito 31
FI - Finlandia 17
SE - Svezia 16
BE - Belgio 15
VN - Vietnam 12
FR - Francia 11
CA - Canada 9
LT - Lituania 5
IN - India 4
HK - Hong Kong 2
EU - Europa 1
GR - Grecia 1
IR - Iran 1
NL - Olanda 1
RU - Federazione Russa 1
Totale 3.173
Città #
Warsaw 296
Fairfield 273
Ferrara 243
Woodbridge 216
Ann Arbor 153
Singapore 125
Chandler 118
Houston 110
Ashburn 109
Seattle 103
Cambridge 93
Wilmington 79
Jacksonville 76
Santa Clara 49
Jakarta 47
Beijing 45
Izmir 44
New York 39
Princeton 36
Shanghai 30
Nanjing 25
Addison 21
San Diego 18
Munich 17
Bologna 15
Brussels 14
Dong Ket 12
Rimini 12
Boardman 11
Nanchang 10
Bremen 9
Dearborn 9
Milan 9
Auburn Hills 8
Catania 7
Los Angeles 7
Shenyang 7
Ariano nel Polesine 6
Chicago 6
Toronto 6
Mountain View 5
Norwalk 5
Cagliari 4
Changsha 4
Hebei 4
Hounslow 4
Rome 4
San Mateo 4
Treviso 4
Falls Church 3
Hefei 3
Helsinki 3
Jiaxing 3
Jinan 3
Kunming 3
London 3
Monmouth Junction 3
Savignano sul Rubicone 3
Tianjin 3
Zhengzhou 3
Arezzo 2
Augusta 2
Ferrara di Monte Baldo 2
Florence 2
Haikou 2
Hangzhou 2
Hong Kong 2
Leawood 2
Modena 2
Orange 2
Ottawa 2
Ozzano dell'Emilia 2
Parma 2
Pegola 2
Redwood City 2
San Mauro Pascoli 2
Vazzola 2
Venice 2
Washington 2
Ardabil 1
Bangalore 1
Bentivoglio 1
Castel di Casio 1
Changchun 1
Cremenaga 1
Crotone 1
Delhi 1
Des Moines 1
Frankfurt am Main 1
Imola 1
Kilburn 1
Lanzhou 1
Lappeenranta 1
Montreal 1
Nagold 1
Ningbo 1
Osio Sotto 1
Palermo 1
Pasadena 1
Philadelphia 1
Totale 2.643
Nome #
RUOLO DI VAV1 NELLA MATURAZIONE DI PROMIELOCITI TUMORALI APL-DERIVATI 180
A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report 164
In triple negative breast tumor cells, PLC-beta 2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness 146
Vav1 is necessary for PU.1 mediated upmodulation of miR-29b in acute myeloid leukaemia-derived cells 140
null 134
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 128
Up-modulation of PLC-beta2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: A promising target for preventing progression of TNBC 126
High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process 123
Risk factors associated with relapse of eyelid basal cell carcinoma: results from a retrospective study of 142 patients 118
Vav1 downmodulates Akt in different breast cancer subtypes: A new promising chance to improve breast cancer outcome 115
Mass spectrometry-based identification of Y745 of Vav1 as a tyrosine residue crucial in maturation of acute promyelocytic leukemia-derived cells 115
Vav1 is a crucial molecule in monocytic/macrophagic differentiation of myeloid leukemia-derived cells 114
CD133 in Breast Cancer Cells: More than a Stem Cell Marker 114
Protective role of all-trans retinoic acid (ATRA) against hypoxia-induced malignant potential of non-invasive breast tumor derived cells 113
Nuclear proteome analysis reveals a role of Vav1 in modulating RNA processing during maturation of tumoral promyelocytes 109
Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: Role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation 105
Vav1 in differentiation of tumoral promyelocytes 104
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 104
hnRNP K in PU.1-containing complexes recruited at theCD11bpromoter: a distinct role in modulating granulocytic and monocytic differentiation of AML-derived cells 101
Vav1 modulates protein expression during ATRA-induced maturation of APL-derived promyelocytes: a proteomic-based analysis. 101
RNA interference in the study of molecular mechanisms activated during agonist induced differentiation of acute promyelocytic leukemia derived promyelocytes 80
Pulsed Electromagnetic Fields Modulate miRNAs During Osteogenic Differentiation of Bone Mesenchymal Stem Cells: a Possible Role in the Osteogenic-angiogenic Coupling 64
Ethanol-based garlic extract prevents malignant evolution of non-invasive breast tumor cells induced by moderate hypoxia 62
Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer 57
The Molecular Networks of microRNAs and Their Targets in the Drug Resistance of Colon Carcinoma 45
Vav1 Down-Modulates Akt2 Expression in Cells from Pancreatic Ductal Adenocarcinoma: Nuclear Vav1 as a Potential Regulator of Akt Related Malignancy in Pancreatic Cancer 39
Deregulated microRNAs in breast ductal carcinoma in situ (DCIS) with invasive propensity 39
In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness 38
Effects of garlic extract on breast tumor cells: a phenotype dependent modulation of morphology, cell cycle and invasive potential 36
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer 36
Vav1 Sustains the In Vitro Differentiation of Normal and Tumor Precursors to Insulin Producing Cells Induced by all-Trans Retinoic Acid (ATRA) 36
Targeting the Vav1/miR‐29b axis as a potential approach for treating selected molecular subtypes of triple‐negative breast cancer 32
The Motility and Mesenchymal Features of Breast Cancer Cells Correlate with the Levels and Intracellular Localization of Transglutaminase Type 2 31
ROLE OF VAV1 IN DIFFERENTIATION ALONG THE MONOCYTIC-MACROPHAGIC LINEAGE OF TUMORAL MYELOID PRECURSORS 29
EVALUATION OF DIFFERENT STORAGE CONDITIONS ON CHEMICAL COMPOSITION AND BIOACTIVE COMPOUNDS OF VOGHIERA GARLIC PDO 25
Transcriptomics Studies Reveal Functions of Transglutaminase 2 in Breast Cancer Cells Using Membrane Permeable and Impermeable Inhibitors 24
The Effect of Different Storage Conditions on Phytochemical Composition, Shelf-Life, and Bioactive Compounds of Voghiera Garlic PDO 22
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 22
Vav1 regulates phenotypic differentiation of AML-derived promyelocytes to monocytes/macrophages 22
PLC-β2 is modulated by low oxygen availability in breast tumor cells and plays a phenotype dependent role in their hypoxia-related malignant potential 21
Investigating intra- and extra-cellular functions of Transglutaminase 2 by use of inhibitors with different localization in breast cancer cells 18
THE MULTIDOMAIN PROTEIN VAV1 IN THE DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO INSULIN-PRODUCING CELLS 16
Mir-29b in Breast Cancer: A Promising Target for Therapeutic Approaches 13
Vav1 Selectively Down-Regulates Akt2 through miR-29b in Certain Breast Tumors with Triple Negative Phenotype 10
Phenotype-dependent role of Vav1 in down-modulating Akt in invasive breast tumor cells 9
Traditional versus progressive robot-assisted gait training in people with multiple sclerosis and severe gait disability: study protocol for the PROGR-EX randomised controlled trial 6
Totale 3.286
Categoria #
all - tutte 16.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.958


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020412 0 0 0 0 39 57 57 69 62 59 44 25
2020/2021649 26 29 35 39 133 77 64 72 18 76 38 42
2021/2022333 12 24 30 17 9 32 23 16 8 43 22 97
2022/2023316 36 19 21 29 41 27 22 49 36 2 20 14
2023/2024321 18 26 3 10 20 60 12 43 8 13 23 85
2024/2025343 52 41 115 63 72 0 0 0 0 0 0 0
Totale 3.286